Nurix Therapeutics Inc (NRIX) Smart Money Holdings (13F, Q2 2026)

NRIX ranks #2834 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

NRIX is a top-conviction position for Redmile Group, LLC — at 6.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in NRIX belongs to BlackRock, Inc., but the position matters far more to Redmile Group, LLC, who has 6.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Farther Finance Advisors, LLC has added to its NRIX position for two straight quarters, increasing it by $89.6K to reach $95.2K today.

NRIX is down 2.1% today, but institutions show net buying of $202.6M this quarter — a divergence between today's price move and the underlying institutional flow.

NRIX reported a net loss of $341.4M over the trailing twelve months.

• Not yet profitable — net loss of $341.4M over the trailing twelve months
• Revenue declined 58.4% year over year
• Net income declined year over year, from -$207.3M to -$341.4M
• Operating cash flow was negative, using $249.5M in cash
• Current ratio of 7.02x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.28x equity — within a conventional range